Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 3: Angiotensin-converting-enzyme inhibitors

CMAJ. Canadian Medical Association Journal

Volumn 163, Issue 3, 2000, Pages 293-296

  Wright, J M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE; FOSINOPRIL; LISINOPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; THIAZIDE DIURETIC AGENT;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; META ANALYSIS; REVIEW;

EID: 0034622464     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1: Thiazide diuretics
2. Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 2: B-Blockers
3. Systematic review of antihypertensive therapies: Does the evidence assist in choosing a first-line drug?
4. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
5. A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension the GLANT Study
6. The effect of nisoldipine as compared with enalapril on cardiovascular out-comes m patients with non-insulin-dependent diabetes and hypertension
7. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
8. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascuular mortality and morbidity. The Swedish Trial in Old Patients with Hypertension-2 Study
9. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
10. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
11. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
12. Secondary prevention in acute myocardial infarction
13. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis
14. Effect of angiotensin-converting enzyme inhibitors on the progression of non-diabetic renal disease: A meta-analysis of randomised trials
15. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
16. Treatment of Mild Hypertension Study. Final results
17. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: Results of the HANE study
18. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)
19. Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials
20. ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management